-The Hindu The world cannot afford to talk about hunger without addressing climate change, food production without sustainability or growth without good nutrition With the world's population predicted to reach 9 billion by 2050, we collectively face a dual challenge: ensuring that everyone will have access to affordable, nutritious food without decimating the earth's natural resources in the process. This is easier said than done. Our current food system is dysfunctional both...

-The Indian Express Prime Minister Narendra Modi's US visit is likely to throw up highly contentious intellectual property rights issues. Indeed, for the last several years, US drug majors and their European counterparts have lobbied hard to demonise the Indian patent regime. But the government must continue to defend the law and stand its ground. Particularly since our own industrial moguls have caved in and are less vocal about their opposition...

-The Business Standard Make schemes mobile and portable, by focusing on people and not products India spends close to four per cent of its GDP on an alphabet soup of welfare schemes and subsidies - it has become a welfare state before becoming a developed state. Despite its significant costs, India's welfare system is neither comprehensive nor very effective - subject to huge leakages and corruption, and not well knit into...

-The Times of India NEW DELHI: Faced with the scary prospect of losing lives to simple infections in the future, India is finally waking up to the dangers of reckless antibiotic use. The Indian Medical Association, a pan-India voluntary organization of doctors, will on Sunday launch a nationwide awareness programme on overuse of these live-savers, a practice that has led to emergence of drug-resistant organisms. IMA will also ask fellow practitioners to...

-The Times of India MUMBAI: In a move that will disappoint many patients, the government has withdrawn certain powers of the drug pricing regulator that allowed it to cap prices of widely prescribed anti-diabetes, cancer, HIV, tuberculosis and cardiac medicines. The National Pharmaceutical Pricing Authority (NPPA) said it is withdrawing "with immediate effect" - a guideline that had allowed it to put price caps on crucial medicines - to comply with a...